Aims and Scope
Instructions for Authors
Instructions for Reviewers
Ahead of Print
Most Read Articles
Most Cited Articles
Korean J Intern Med Search
> Browse Articles > Korean J Intern Med Search
Aromatase inhibitor use is a risk factor of
presence in endocrine-responsive breast cancer patients
Da Hea Seo, Yongin Cho, Sujin Lee, Seho Park, Seung-Il Kim, Byeong Woo Park, Yumie Rhee
Korean J Intern Med.
2019;34(3):579-587. Published online August 25, 2017
Background/Aims: The aromatase inhibitors (AIs) are well known anti-hormonal therapy in endocrine-responsive breast cancer patients. It can lead to dyslipidemia and be the risk factor of cardiovascular disease due to low estrogen level. However, some recent studies comparing AIs with placebo have sh..
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792 Fax: +82-2-790-0993 E-mail:
Copyright © 2019 The Korean Association of Internal Medicine. All rights reserved.
For Authors and Reviewers